Human Papillomavirus (HPV) Vaccines: Limited Cross-Protection against Additional HPV Types

被引：86

作者：

Herrero, Rolando ^{[1
]}

机构：

[1] Fdn INCIENSA, San Jose, Costa Rica

来源：

JOURNAL OF INFECTIOUS DISEASES | 2009年 / 199卷 / 07期

关键词：

INVASIVE CERVICAL-CANCER; WOMEN; VACCINATION;

D O I：

10.1086/597308

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：919 / 922

页数：4

共 12 条

[1] The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16-26 Years [J].

Brown, Darron R. ;

Kjaer, Susanne K. ;

Sigurdsson, Kristjan ;

Iversen, Ole-Erik ;

Hernandez-Avila, Mauricio ;

Wheeler, Cosette M. ;

Perez, Gonzalo ;

Koutsky, Laura A. ;

Tay, Eng Hseon ;

Garcia, Patricia ;

Ault, Kevin A. ;

Garland, Suzanne M. ;

Leodolter, Sepp ;

Olsson, Sven-Eric ;

Tang, Grace W. K. ;

Ferris, Daron G. ;

Paavonen, Jorma ;

Steben, Marc ;

Bosch, F. Xavier ;

Dillner, Joakim ;

Joura, Elmar A. ;

Kurman, Robert J. ;

Majewski, Slawomir ;

Munoz, Nubia ;

Myers, Evan R. ;

Villa, Luisa L. ;

Taddeo, Frank J. ;

Roberts, Christine ;

Tadesse, Amha ;

Bryan, Janine ;

Lupinacci, Lisa C. ;

Giacoletti, Katherine E. D. ;

Sings, Heather L. ;

James, Margaret ;

Hesley, Teresa M. ;

Barra, Eliav .

JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (07) :926-935

[2] Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer [J].

Combita, AL ;

Bravo, MM ;

Touzé, A ;

Orozco, O ;

Coursaget, P .

INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (06) :796-803

[3] Cervical cancer screening following prophylactic human papillomavirus vaccination [J].

Franco, Eduardo L. ;

Cuzick, Jack .

VACCINE, 2008, 26 :A16-A23

[4] A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: Importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention [J].

Jenkins, David .

GYNECOLOGIC ONCOLOGY, 2008, 110 (03) :S18-S25

[5] Epidemiologic classification of human papillomavirus types associated with cervical cancer [J].

Muñoz, N ;

Bosch, FX ;

de Sanjosé, S ;

Herrero, R ;

Castellsagué, X ;

Shah, KV ;

Snijders, PJF ;

Meijer, CJLM .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (06) :518-527

[6] Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women:: an interim analysis of a phase III double-blind, randomised controlled trial [J].

Paavonen, Jorma ;

Jenkins, David ;

Bosch, F. Xavier ;

Naud, Paulo ;

Salmeron, Jorge ;

Wheeler, Cosette M. ;

Chow, Song-Nan ;

Apter, Dan L. ;

Kitchener, Henry C. ;

Castellsague, Xavier ;

de Carvalho, Newton S. ;

Skinner, S. Rachel ;

Harper, Diane M. ;

Hedrick, James A. ;

Jaisamrarn, Unnop ;

Limson, Genara A. M. ;

Dionne, Marc ;

Quint, Wim ;

Spiessens, Bart ;

Peeters, Pascal ;

Struyf, Frank ;

Wieting, Susan L. ;

Lehtinen, Matti O. ;

Dubin, Gary .

LANCET, 2007, 369 (9580) :2161-2170

[7] The carcinogenicity of human papillornavirus types reflects viral evolution [J].

Schiffman, M ;

Herrero, R ;

DeSalle, R ;

Hildesheim, A ;

Wacholder, S ;

Rodriguez, AC ;

Bratti, MC ;

Sherman, ME ;

Morales, J ;

Guillen, D ;

Alfaro, M ;

Hutchinson, M ;

Wright, TC ;

Solomon, D ;

Chen, ZG ;

Schussler, J ;

Castle, PE ;

Burk, RD .

VIROLOGY, 2005, 337 (01) :76-84

[8] Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing [J].

Schiffman, Mark .

CANCER CYTOPATHOLOGY, 2007, 111 (03) :145-153

[9] Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update [J].

Smith, Jennifer S. ;

Lindsay, Lisa ;

Hoots, Brooke ;

Keys, Jessica ;

Franceschi, Silvia ;

Winer, Rachel ;

Clifford, Gary M. .

INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (03) :621-632

[10] Antibodies from women immunized with Gardasil® cross-neutralize HPV 45 pseudovirions [J].

Smith, Judith F. ;

Brownlow, Michelle ;

Brown, Martha ;

Kowalski, Rose ;

Esser, Mark T. ;

Ruiz, Wanda ;

Barr, Eliav ;

Brown, Darron R. ;

Bryan, Janine T. .

HUMAN VACCINES, 2007, 3 (04) :109-115

← 1 2 →